These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 20687105

  • 1. Differential effects of stress on [¹¹C]raclopride and [¹¹C]MNPA binding to striatal D₂/D₃ dopamine receptors: a PET study in conscious monkeys.
    Tsukada H, Ohba H, Nishiyama S, Kakiuchi T.
    Synapse; 2011 Jan; 65(1):84-9. PubMed ID: 20687105
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D(2/3) receptor occupancy of apomorphine in the nonhuman primate brain--a comparative PET study with [11C]raclopride and [11C]MNPA.
    Finnema SJ, Halldin C, Bang-Andersen B, Gulyás B, Bundgaard C, Wikström HV, Farde L.
    Synapse; 2009 May; 63(5):378-89. PubMed ID: 19173265
    [Abstract] [Full Text] [Related]

  • 3. Occupancy of dopamine D2/3 receptors in rat brain by endogenous dopamine measured with the agonist positron emission tomography radioligand [11C]MNPA.
    Seneca N, Zoghbi SS, Skinbjerg M, Liow JS, Hong J, Sibley DR, Pike VW, Halldin C, Innis RB.
    Synapse; 2008 Oct; 62(10):756-63. PubMed ID: 18651641
    [Abstract] [Full Text] [Related]

  • 4. Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine.
    Kodaka F, Ito H, Takano H, Takahashi H, Arakawa R, Miyoshi M, Okumura M, Otsuka T, Nakayama K, Halldin C, Farde L, Suhara T.
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):83-9. PubMed ID: 20860881
    [Abstract] [Full Text] [Related]

  • 5. Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride.
    Seneca N, Finnema SJ, Farde L, Gulyás B, Wikström HV, Halldin C, Innis RB.
    Synapse; 2006 Apr; 59(5):260-9. PubMed ID: 16416444
    [Abstract] [Full Text] [Related]

  • 6. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
    Peng T, Zysk J, Dorff P, Elmore CS, Ström P, Malmquist J, Ding M, Tuke D, Werkheiser J, Widzowski D, Mrzljak L, Maier D.
    Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
    [Abstract] [Full Text] [Related]

  • 7. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R, Slifstein M, Guillin O, Hwang Y, Hwang DR, Scher E, Reeder S, Rabiner E, Laruelle M.
    Synapse; 2006 Dec 01; 60(7):485-95. PubMed ID: 16952157
    [Abstract] [Full Text] [Related]

  • 8. Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]raclopride.
    Kodaka F, Ito H, Kimura Y, Fujie S, Takano H, Fujiwara H, Sasaki T, Nakayama K, Halldin C, Farde L, Suhara T.
    Eur J Nucl Med Mol Imaging; 2013 Apr 01; 40(4):574-9. PubMed ID: 23238524
    [Abstract] [Full Text] [Related]

  • 9. A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey.
    Finnema SJ, Seneca N, Farde L, Shchukin E, Sóvágó J, Gulyás B, Wikström HV, Innis RB, Neumeyer JL, Halldin C.
    Nucl Med Biol; 2005 May 01; 32(4):353-60. PubMed ID: 15878504
    [Abstract] [Full Text] [Related]

  • 10. (18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study.
    Finnema SJ, Stepanov V, Nakao R, Sromek AW, Zhang T, Neumeyer JL, George SR, Seeman P, Stabin MG, Jonsson C, Farde L, Halldin C.
    J Nucl Med; 2014 Jul 01; 55(7):1164-70. PubMed ID: 24790219
    [Abstract] [Full Text] [Related]

  • 11. Agonist binding fraction of dopamine D2/3 receptors in rat brain: a quantitative autoradiographic study.
    Minuzzi L, Cumming P.
    Neurochem Int; 2010 Jul 01; 56(6-7):747-52. PubMed ID: 20117160
    [Abstract] [Full Text] [Related]

  • 12. Measurement of the proportion of D2 receptors configured in state of high affinity for agonists in vivo: a positron emission tomography study using [11C]N-propyl-norapomorphine and [11C]raclopride in baboons.
    Narendran R, Hwang DR, Slifstein M, Hwang Y, Huang Y, Ekelund J, Guillin O, Scher E, Martinez D, Laruelle M.
    J Pharmacol Exp Ther; 2005 Oct 01; 315(1):80-90. PubMed ID: 16014571
    [Abstract] [Full Text] [Related]

  • 13. Kinetic brain analysis and whole-body imaging in monkey of [11C]MNPA: a dopamine agonist radioligand.
    Seneca N, Skinbjerg M, Zoghbi SS, Liow JS, Gladding RL, Hong J, Kannan P, Tuan E, Sibley DR, Halldin C, Pike VW, Innis RB.
    Synapse; 2008 Sep 01; 62(9):700-9. PubMed ID: 18566975
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2 and D3 dopamine receptors.
    Skinbjerg M, Namkung Y, Halldin C, Innis RB, Sibley DR.
    Synapse; 2009 Jun 01; 63(6):462-75. PubMed ID: 19217026
    [Abstract] [Full Text] [Related]

  • 15. Long-term test-retest reliability of striatal and extrastriatal dopamine D2/3 receptor binding: study with [(11)C]raclopride and high-resolution PET.
    Alakurtti K, Johansson JJ, Joutsa J, Laine M, Bäckman L, Nyberg L, Rinne JO.
    J Cereb Blood Flow Metab; 2015 Jul 01; 35(7):1199-205. PubMed ID: 25853904
    [Abstract] [Full Text] [Related]

  • 16. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
    Tsukada H, Harada N, Nishiyama S, Ohba H, Sato K, Fukumoto D, Kakiuchi T.
    Synapse; 2000 Aug 01; 37(2):95-103. PubMed ID: 10881030
    [Abstract] [Full Text] [Related]

  • 17. Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography study.
    Narendran R, Martinez D, Mason NS, Lopresti BJ, Himes ML, Chen CM, May MA, Price JC, Mathis CA, Frankle WG.
    Synapse; 2011 Dec 01; 65(12):1344-9. PubMed ID: 21780185
    [Abstract] [Full Text] [Related]

  • 18. Quantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-propylnorapomorphine in the human brain.
    Otsuka T, Ito H, Halldin C, Takahashi H, Takano H, Arakawa R, Okumura M, Kodaka F, Miyoshi M, Sekine M, Seki C, Nakao R, Suzuki K, Finnema S, Hirayasu Y, Suhara T, Farde L.
    J Nucl Med; 2009 May 01; 50(5):703-10. PubMed ID: 19372485
    [Abstract] [Full Text] [Related]

  • 19. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.
    Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J, Hornykiewicz O, Furukawa Y, Wilson AA, Kapur S, Kish SJ.
    Brain; 2009 May 01; 132(Pt 5):1366-75. PubMed ID: 19153147
    [Abstract] [Full Text] [Related]

  • 20. Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain.
    Tsukada H, Harada N, Nishiyama S, Ohba H, Kakiuchi T.
    J Neurosci; 2000 Sep 15; 20(18):7067-73. PubMed ID: 10995853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.